NDC Package 62135-312-12 Anagrelide

Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
62135-312-12
Package Description:
120 CAPSULE in 1 BOTTLE
Product Code:
Proprietary Name:
Anagrelide
Non-Proprietary Name:
Anagrelide
Substance Name:
Anagrelide Hydrochloride Anhydrous
Usage Information:
Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.
11-Digit NDC Billing Format:
62135031212
NDC to RxNorm Crosswalk:
  • RxCUI: 597850 - anagrelide HCl 0.5 MG Oral Capsule
  • RxCUI: 597850 - anagrelide 0.5 MG Oral Capsule
  • RxCUI: 597850 - anagrelide 0.5 MG (as anagrelide HCl) Oral Capsule
  • RxCUI: 597852 - anagrelide HCl 1 MG Oral Capsule
  • RxCUI: 597852 - anagrelide 1 MG Oral Capsule
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Chartwell Rx, Llc
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Sample Package:
    No
    FDA Application Number:
    ANDA076683
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    04-18-2005
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 62135-312-12?

    The NDC Packaged Code 62135-312-12 is assigned to a package of 120 capsule in 1 bottle of Anagrelide, a human prescription drug labeled by Chartwell Rx, Llc. The product's dosage form is capsule and is administered via oral form.

    Is NDC 62135-312 included in the NDC Directory?

    Yes, Anagrelide with product code 62135-312 is active and included in the NDC Directory. The product was first marketed by Chartwell Rx, Llc on April 18, 2005 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 62135-312-12?

    The 11-digit format is 62135031212. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-262135-312-125-4-262135-0312-12